Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vitamin K to Slow Progression of Cardiovascular Disease Risk in Hemodialysis Patients (Vita-K 'n' CKD Study)

NCT03311321 is registered in ClinicalTrials.gov with Augusta University as lead sponsor.

NCT NCT03311321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03311321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vitamin K to Slow Progression of Cardiovascular Disease Risk in Hemodialysis Patients (Vita-K 'n' CKD Study)
Lead sponsor
Augusta University
Phase
Not applicable
Overall status
Unknown status
Start date
September 13, 2017
Completion date
December 30, 2021
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, chronic kidney disease stage 3, chronic kidney disease stage 4, chronic kidney disease stage 5, hemodialysis, vitamin k deficiency